The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharma, S. A.
Right arrow Articles by Kerr, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, S. A.
Right arrow Articles by Kerr, L. D.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1998, 160: 2401-2407.
Copyright © 1998 by The American Association of Immunologists

Activation of IL-8 Gene Expression by Helicobacter pylori Is Regulated by Transcription Factor Nuclear Factor-{kappa}B in Gastric Epithelial Cells1

Smita A. Sharma*, Murali K. R. Tummuru*, Martin J. Blaser*,{dagger} and Lawrence D. Kerr2,{dagger},{ddagger}

* Division of Infectious Diseases, Department of Medicine, {dagger} Department of Microbiology and Immunology, and {ddagger} Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, TN 37232


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In vivo, gastric infection with Helicobacter pylori leads to substantial production of the inflammatory cytokines IL-1, IL-6, TNF-{alpha}, and IL-8. H. pylori strains that contain the cag pathogenicity island (cag+) and are associated with ulceration and gastric carcinoma induce greater cytokine production than cag- strains. Expression of these cytokines is often regulated by the transcription factor complex, nuclear factor-{kappa}B (NF-{kappa}B) through {kappa}B-binding elements in the enhancer/promoter regions of their genes. We report that more virulent cag+ H. pylori strains induce increased NF-{kappa}B-DNA binding activity, which elevates IL-8 expression in AGS gastric epithelial cells. The cag+ H. pylori strains induce significant stimulation of IL-8 promoter-driven reporter activity, while cag- strains do not. Furthermore, mutation of specific genes within the cag island (picA1 and picB) ablates enhanced NF-{kappa}B activation and IL-8 transcription. Increased IL-8 expression is inhibited by mutation in either the NF-{kappa}B or NF-IL-6 binding element. The cag+ strains, compared with the cag- strains, induce enhanced nuclear localization of a RelA-containing NF-{kappa}B binding complex, but no increase in NF-IL-6 binding activity. These studies demonstrate that the ability of different types of H. pylori strains to activate NF-{kappa}B correlates with their ability to induce IL-8 transcription and indicate a mechanism for the heightened inflammatory response seen in subjects infected with cag+ H. pylori strains.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Infection with the Gram-negative bacterium Helicobacter pylori leads to diverse clinical and pathologic outcomes in humans, including chronic superficial gastritis, duodenal or gastric ulceration, and adenocarcinoma of the stomach (1, 2, 3, 4, 5, 6). One hypothesis is that infection with specific H. pylori strains that possess the cag pathogenicity island (cag+) causes peptic ulceration and gastric carcinoma (7, 8, 9). Recent studies reveal that the cag region is comprised of approximately 40 kb of DNA that is absent in cag- strains (10). An 87-kDa secreted cytotoxin (10, 11) and the picB gene product, both of which are usually expressed by cag+ strains, have been implicated in H. pylori pathogenesis (10, 11, 12, 13, 14, 15, 16). The cytotoxin produces vacuolation of cells (11, 17), whereas the picB product is linked to inflammatory processes (10, 16). The picB product is homologous to proteins known to be involved in secretion from bacterial cells (10, 16), and other homologues of this pathway have been identified in the cag island (10).

Studies of gastric biopsies from patients infected with H. pylori indicate that cag+ strains induce significantly more IL-1{alpha}, IL-1ß, and IL-8 than do cag- strains (18). IL-8, a potent T cell and neutrophil chemoattractant and activating agent, is considered an important factor in the pathogenesis of inflammatory diseases (19). Consistent with the in vivo observations, cag+ H. pylori strains induce significantly greater IL-8 mRNA and protein in gastric epithelial cells in vitro than do cag- strains (20, 21). The H. pylori picB gene (also called cagE) product is required for IL-8 expression, since its mutation abrogates this response (10, 16). Recent studies indicate that mutation of homologues of other genes in the secretory pathway ablates IL-8 secretion (10).

However, little is known about the early events following host-bacterium interactions that influence the course of H. pylori colonization. Signals generated in response to infection, stress, and injury activate nuclear factor-{kappa}B (NF-{kappa}B),3 a ubiquitous transcription factor complex belonging to the Rel family of proteins (22, 23, 24, 25). In most cells, except mature B cells, macrophages, and some neurons, NF-{kappa}B complexes are sequestered in the cytoplasm by inhibitory molecules, termed I{kappa}Bs (24, 27). Upon stimulation of cells, specific I{kappa}Bs are degraded, and certain NF-{kappa}B factors are stimulated to enter the nucleus, bind its specific cognate DNA site, and subsequently regulate gene transcription (22, 27). In most cells, activation of NF-{kappa}B is critical for the inducible expression of the proinflammatory response genes, including cytokines IL-1ß, IL-6, IL-8, and TNF-{alpha} (24, 27). IL-1 and TNF-{alpha} also activate NF-{kappa}B to initiate an autoregulatory pathway that is thought to be responsible for increasing the magnitude of the inflammatory response (23). The translocation of Rel proteins is induced by bacteria and viral pathogens, immune and inflammatory cytokines, and cytotoxic agents (23, 24, 27). NF-{kappa}B activity is induced in HeLa cells by Shigella flexneri (26) and in macrophages by Staphylococcus aureus and several of its exotoxins (27). There also is enhanced nuclear transport of p50/RelA NF-{kappa}B components in macrophages before Listeria monocytogenes invasion (28).

Activation of NF-{kappa}B is the most crucial step for IL-8 gene transcription in most cells, but C/EBP-like (NF-IL-6), and AP-1 binding sites also are required for IL-8 transcriptional activation by IL-1 or TNF-{alpha} (29). Synergistic interactions between NF-{kappa}B and NF-IL-6 may play an important role in the expression of the acute phase response genes, especially in the transcription of IL-6 and IL-8 genes (30, 31). Depending on the cell line, co-operation between NF-{kappa}B and either NF-IL-6 or AP-1 is sufficient for IL-8 gene activation (29). NF-IL-6 may be the primary co-operator, and in its absence or when the NF-IL-6 site is mutated, an interaction between NF-{kappa}B and AP-1 occurs (29).

In this study we investigated the molecular mechanisms by which H. pylori activates IL-8 gene expression in gastric AGS epithelial cells. We show that both NF-{kappa}B and NF-IL-6 elements are essential for activation of IL-8 gene expression by H. pylori. On exposure to cag+ H. pylori strains, gastric epithelial cells exhibit increased RelA-containing NF-{kappa}B activity, which elevates IL-8 expression and thus contributes to the heightened inflammatory response seen in patients infected with these strains (18).


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Bacterial strains and growth conditions

The H. pylori clinical isolates used in this study were from the culture collection of the Vanderbilt University Campylobacter/Helicobacter Lab (Nashville, TN). Wild-type strains 88-23 (60190) and N6 express the vacuolating cytotoxin (tox+) in vitro and possess the cag region, including cagA and upstream genes picA1, picA2, and picB (16, 32); we recently found that the picA reported previously (32) actually consists of two overlapping open reading frames, now termed picA1 and picA2. Strains 88-22 (Tx-30a) and 87-203 are wild-type isolates that do not possess the cag region and do not express detectable cytotoxin activity (tox-) in vitro (32). Isogenic cagA, picA1 or picB mutants had been prepared by insertion of a kanamycin resistance gene within the cagA, picA1 or picB loci, respectively, in H. pylori strains 88-23, as previously described (16, 32). All H. pylori isolates were cultured on 5% sheep blood agar plates in a microaerobic atmosphere (generated by Campy Pak-Plus, BBL Microbiology Systems, Cockeysville, MD) at 37°C for 24 to 48 h. For all incubations with cell cultures, the bacterial cultures were harvested in PBS (pH 7.4) and resuspended to yield a concentration of 5 x 1010 CFU/ml. Stock cultures were maintained at -70°C in brucella broth (BBL Microbiology Systems) supplemented with 15% glycerol.

DNA constructs

The pIL-8(wt)/CAT, pIL-8(-{kappa}B)/CAT, and pIL-8(-5'NF)CAT were provided by Dr. Charles Kunsch and have been described previously (30). Briefly, in these reporter constructs, chloramphenicol acetyltransferase (CAT) expression is under control of the human IL-8 genomic sequence from -420 to +101 bp. Specific substitution mutations were introduced into the IL-8 promoter region to disrupt the NF-{kappa}B binding site (designated pIL-8(-{kappa}B)CAT) and a 5' NF-IL-6 binding site (designated pIL-8(-5' NF)CAT) located between -92 and -71 bp (30).

Cell culture and transient transfection

Human gastric cancer cell line AGS (CRL 1739) obtained from American Type Culture Collection (Rockville, MD) was grown in DMEM containing 5% FCS (HyClone Laboratory, Logan, UT), gentamicin (20 mg/l), and L-glutamine (2 mM) in a humidified incubator containing 5% CO2, as previously described (21). For transient transfection assays, AGS epithelial cells were grown in individual 100-mm3 culture plates to ~60% confluence, at which time 10 µg of the CAT reporter constructs under control of the IL-8 promoter were transfected by the calcium phosphate/DNA coprecipitation procedure (33, 34). These constructs were cotransfected with 1 µg of Rous sarcoma virus-ß-galactosidase construct for determination of transfection efficiency. The transfected AGS cells then were incubated in 0.5% FCS medium without antibiotics for 24 h in the absence or the presence of TNF-{alpha} (103 U/ml) or H. pylori cells at a concentration of 109/ml (cell to bacteria ratio of 1:1000), as described previously (21). AGS cells were collected by scraping, suspended in 100 µl of 0.25 M Tris-HCl (pH 8.0), and lysed by four repeated freeze-thaw cycles. Equal amounts of protein from different cell extracts were assayed for CAT activity, as previously described (35). Each experiment was performed four times with at least two different plasmid preparations.

Nuclear extract preparation

Nuclear extracts from AGS cells were prepared as previously described (36). After the treatment indicated, cells were scraped, centrifuged, and washed in cold Tris-buffered saline (pH 7.9), and then resuspended in 400 µl of cold buffer A (10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF, 1 mM aprotinin, 14 mM leupeptin, 1 mM pepstatin, and 80 µg of benzamidine/ml). After the cells were allowed to swell on ice for 15 min, they were lysed by vigorous vortexing for 10 s in the presence of Nonidet P-40 (final concentration, 1.0%). The homogenate was centrifuged for 30 s at 13,000 x g, and the nuclear pellet was resuspended in 50 µl of cold buffer C (20 mM HEPES (pH 7.9), 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 1 mM aprotinin, 14 mM leupeptin, 1 mM pepstatin, and 80 µg of benzamidine/ml). This suspension was agitated at 4°C for 15 min with a Vortex-Genie 2 (Scientific Industries, Inc., Bohemia, NY) with a multiple sample head at setting 5, followed by microcentrifugation for 5 min at 4°C. The resulting supernatant was stored in small aliquots at -80°C. Protein concentrations were determined as previously described (37).

Preparation of radiolabeled DNA probes and electrophoretic mobility shift assay (EMSA)

EMSAs were performed as previously described (38). All oligonucleotides were synthesized by the Vanderbilt University DNA Core. Double-stranded oligonucleotide-{kappa}B (5'-CGTGGAATTTCCTCTG-3', -83 to -68 bp) and wild-type CEBP/NF-IL-6 (5'-CATCAGTTGCAAATCGTGG-3', -97 to -79 bp) binding sites from the IL-8 promoter were end labeled with [{alpha}-32P]dATP (6000 Ci/mmol) using the Klenow fragment of Escherichia coli DNA polymerase I (Pharmacia, Piscataway, NJ), were used as probes. The binding reactions (38) were performed on ice in a volume of 25 ml and contained 5 ml of 5x binding buffer (50 mM Tris-HCl (pH 7.9), 250 mM NaCl, 2.5 mM EDTA, 50% glycerol, and 5 mM DTT), 5 to 10 µg of nuclear proteins, and 2.0 µg of poly(dI-dC) (Boehringer Mannheim, Indianapolis, IN). After 30 min on ice, 30,000 cpm of 32P-labeled DNA probe was added to the reaction mixture for 30 min at ambient temperature. The DNA-protein complexes were separated on native 4% polyacrylamide gels (prerun at 150 V for 1.5 h) in Tris glycine buffer at 150 V for 2 to 4 h at ambient temperature. After electrophoresis was performed, the gels were dried and exposed for autoradiography at -70°C for 24 to 36 h. In competition studies, a 25-fold molar excess of unlabeled wild-type oligonucleotides or oligonucleotides containing mutant NF-{kappa}B (5'-CGTtaAcTTTCCTCTG) or CEBP/NF-IL-6 (5'-CATagcTTGCAAATCGTGG-3') binding sites was included in the reaction mixture along with the radiolabeled probe. For supershift experiments, affinity-purified rabbit Abs (2 µg/reaction) to p50, RelA, c-Rel, or p52 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) were included in the standard reaction mixture and incubated on ice for 30 min before the labeled oligonucleotides were added.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Activation of IL-8 gene transcription by H. pylori is mediated by NF-{kappa}B and NF-IL-6 in AGS epithelial cells

Molecular analysis of the 5' flanking region of the IL-8 gene has revealed that putative C/EBP, NF-{kappa}B, and AP-1 binding sites are important in regulating IL-8 gene transcription (29, 30, 39). Sequences from -94 and -71 bp of the IL-8 promoter consisting of NF-{kappa}B and NF-IL-6 binding sites are essential for responsiveness to IL-1 or TNF-{alpha} in human fibrosarcoma 8387 cells and glioblastoma T98G cells (29), whereas in Jurkat T cells, both are required for maximal IL-8 transcriptional activation by phorbol ester and TNF-{alpha} (30). Since H. pylori induces IL-8 mRNA and protein levels in gastric epithelial cells (20, 21, 40), we examined whether this induction is mediated at the level of transcription. To this end, human gastric AGS epithelial cells were transiently transfected with a wild-type IL-8 promoter/CAT reporter gene construct (pIL-8(wt)/CAT, which spans from -420 to +101 bp of the IL-8 gene) and then stimulated with live cells of cag+ H. pylori strain 88-23 or with TNF-{alpha} as a positive control. Assay of CAT activity revealed 10.8- and 4.5-fold increases in response to TNF-{alpha} and H. pylori stimulation, respectively (Fig. 1Go). These results indicated that H. pylori induces IL-8 expression in AGS cells at the level of transcription.



View larger version (29K):
[in this window]
[in a new window]
  		FIGURE 1. NF-{kappa}B and NF-IL-6 binding sites are required for H. pylori- and TNF-{alpha}-mediated induction of IL-8 expression in AGS epithelial cells. AGS cells were transfected with 10 µg of the indicated reporter plasmids for 24 h and were treated in the absence of antibiotics with 0.5% FCS medium alone or 0.5% FCS medium containing either live H. pylori cells or 103 U of TNF-{alpha} for an additional 24 h before samples for CAT assays were harvested. The CAT activity from the reporter plasmid was normalized to the ß-galactosidase activity from the cotransfected Rous sarcoma virus-ß-galactosidase expression plasmid. The results are presented relative to the use of FCS medium control alone, as the mean ± SE of four experiments.

 
To assess whether the NF-{kappa}B and/or the NF-IL-6 binding sequences in the IL-8 promoter may contribute to the stimulatory activities by H. pylori, transient transfections with mutant IL-8 promoter/CAT reporter gene constructs with specific mutations in either the NF-{kappa}B (designated pIL-8(-{kappa}B)CAT) or the NF-IL-6 (designated pIL-8(-5' NF)CAT) binding site (30) were performed in parallel studies (Fig. 1Go). Mutation in either the 5' NF-IL-6 site or the NF-{kappa}B site in the IL-8 promoter significantly reduced TNF-{alpha}-mediated CAT activity in gastric cells and essentially abolished activation by H. pylori. These experiments indicated that activation of the IL-8 promoter in gastric AGS epithelial cells in response to H. pylori stimulation requires intact binding sites for both the NF-{kappa}B and the NF-IL-6 elements.

H. pylori pic gene products are required for induction of IL-8 promoter activity in AGS epithelial cells

Since recent studies indicated that in AGS epithelial cells, the pic gene products were essential for the enhanced IL-8 mRNA and protein levels induced by cag+ strains (16), we sought to determine whether these products also are essential for H. pylori-induced IL-8 promoter activity in AGS cells. Inducible activation of IL-8 promoter activity was assayed in AGS cells by transient transfection analysis, as described above. After stimulation with the cag+ H. pylori strain 88-23, there was a 5.2-fold increase in CAT activity (Fig. 2Go). Isogenic picA1 and picB mutants of cag+ strain 88-23 and the wild-type cag- strain 88-22 did not induce IL-8 promoter activity. An isogenic cagA- mutant of strain 88-23 induced IL-8 promoter activity, but at a reduced level. These results indicate that the H. pylori pic gene products are essential for induction of IL-8 promoter activity in AGS cells, which parallels the previously reported IL-8 mRNA and protein responses (16).



View larger version (39K):
[in this window]
[in a new window]
  		FIGURE 2. Products of the cag pathogenicity island are required for induction of IL-8 expression in AGS epithelial cells by cag+ H. pylori cells. AGS cells were transfected with 10 µg of the pIL-8 WT CAT plasmid for 24 h. Samples were treated with 0.5% FCS medium alone (medium control) or with 0.5% FCS medium containing either H. pylori cells or 103 U of TNF-{alpha}. AGS cell lysates were prepared 24 h after stimulation and analyzed for ß-galactosidase and CAT activities. The CAT activity results are presented as described in Figure 1Go, representing a mean of four transfections.

 
Stimulation with H. pylori induces a single predominant {kappa}B binding complex, while NF-IL-6 is constitutively expressed in AGS cells

The transient transfection analysis experiments with the wild-type and mutant IL-8 promoter/CAT reporter gene constructs indicate that both NF-IL-6 and NF-{kappa}B sites are essential for H. pylori and also for TNF-{alpha}-mediated activation of the IL-8 promoter in gastric AGS epithelial cells. To further determine whether the increase in IL-8 expression seen in H. pylori-stimulated gastric epithelial cells was related to alteration in NF-{kappa}B or NF-IL-6 binding activity in the nuclei, nuclear extracts from AGS cell monolayers were prepared, and EMSAs were performed using as probes radiolabeled oligonucleotides representing wild-type IL-8 promoter NF-{kappa}B and NF-IL-6 element sequences. A single predominant {kappa}B binding complex (absent in unstimulated cultures; Fig. 3Go, lane 1) was induced in AGS cells after stimulation with live H. pylori wild-type strain 88-23 (lane 2). The specificity of this inducible {kappa}B-binding factor was confirmed by competition analysis with unlabeled wild-type and mutant oligonucleotides. Rel/NF-{kappa}B proteins appeared to mediate this H. pylori-induced binding, since unlabeled wild-type (lane 3), but not mutant {kappa}B oligonucleotides (lane 4) effectively competed with the induced NF-{kappa}B complex. NF-IL-6 binding was constitutively present in nuclei from unstimulated cultures, appearing as two bands on EMSA (lane 5). Stimulation with H. pylori did not alter this binding (lane 6).



View larger version (80K):
[in this window]
[in a new window]
  		FIGURE 3. Live cells of H. pylori wild-type strain 88-23 induce a prominent NF-{kappa}B binding complex, whereas the NF-IL-6 binding complex is constitutively expressed in AGS cells. Nuclear extracts containing equal protein concentrations from AGS cells unstimulated or stimulated with H. pylori strain 88-23 were analyzed for NF-{kappa}B or NF-IL-6 binding activity by gel-shift assays. The NF-{kappa}B probe (lanes 1–4) or the NF-IL-6 probe (lanes 5–8) was incubated with nuclear extracts from unstimulated (lanes 1 and 5) or H. pylori-stimulated AGS cells alone (lanes 2–4 and 6–8), without (lanes 2 and 6) or with a 25-fold excess of cold wild-type probe (lanes 3 and7) or a 25-fold excess of mutant probe (lanes 4 and 8). The arrow indicates the location of induced {kappa}B binding complex, and the dot indicates the specific NF-IL-6 binding complex.

 
To understand further the mechanism of NF-{kappa}B activation, we studied the kinetics of H. pylori-induced NF-{kappa}B binding in AGS epithelial cells by EMSA. A single DNA-protein complex was induced in nuclear extracts prepared from stimulated AGS cells 1 h after coculture with H. pylori strain 88-23, and similar {kappa}B-DNA binding activity levels were maintained through 4 h (Fig. 4Go). To identify the subunit composition of the induced {kappa}B-DNA binding complex, Abs to Rel family members, Rel A, c-Rel, p50, and p52, were preincubated with the nuclear extracts from AGS cells and used in supershift analysis (Fig. 5Go). As expected, nuclear extracts from AGS cells cocultured with strain 88-23 showed significant stimulation of {kappa}B binding activity (Fig. 5Go, lane 2) compared with unstimulated cells (lane 1). Anti-RelA Ab specifically recognized this stimulated {kappa}B-DNA binding complex, resulting in supershifted complexes (lane 3). Preincubation with anti-c-Rel or anti-p52 Ab did not recognize any of the {kappa}B binding complexes (lanes 4 and5), but preincubation with anti-p50 Ab resulted in the formation of a very faint supershifted complex (lane 6). These results indicate that in AGS cells, a RelA NF-{kappa}B binding complex is rapidly induced in response to H. pylori infection.



View larger version (55K):
[in this window]
[in a new window]
  		FIGURE 4. A {kappa}B binding complex is induced in AGS cells within 1 h of coculture with H. pylori. Nuclear extracts containing equal protein concentrations from AGS cells that were unstimulated or cocultured with H. pylori strain 88-23 were analyzed for {kappa}B binding activity by gel-shift assays using an IL-8 {kappa}B oligonucleotide as a probe. Lane 1, Nuclear extract from unstimulated AGS cells. Lanes 2 to 5, Nuclear extract from AGS cells cocultured with H. pylori for 1 to 4 h. The arrow indicates the position of the induced {kappa}B binding complex.

 


View larger version (63K):
[in this window]
[in a new window]
  		FIGURE 5. Anti-RelA sera recognizes H. pylori-stimulated {kappa}B binding complex in nuclear extracts from AGS cells. Nuclear extracts from AGS cells that were unstimulated or cocultured with H. pylori strain 88-23 were analyzed for {kappa}B binding by gel-shift assays. The {kappa}B probe was incubated with nuclear extracts from AGS cells that were unstimulated (lane 1) or cocultured with H. pylori strain 88-23 (lanes 2–6). The nuclear extracts were preincubated for 30 min with Abs against RelA (lane 3), c-Rel (lane 4), p52 (lane 5), or p50 (lane 6). Arrows indicate the locations of supershifted complexes in lanes 3 and 6.

 
The pic gene products expressed by cag+ H. pylori strains are essential for induction of NF-{kappa}B DNA binding activity in epithelial cells

Since we (21) and others (20) have previously shown that cag+ strains induce significantly more IL-8 mRNA and protein than do cag- wild-type H. pylori strains, we sought to further ascertain whether that difference was related to NF-{kappa}B activation (Fig. 6Go). Markedly increased RelA-NF-{kappa}B-DNA binding activity was induced by wild-type cag+ H. pylori strains (lanes 2–5) compared with the wild-type cag- strains (lanes 6–9). To determine whether the observed difference in {kappa}B-DNA binding activity was specific to the cag region, we next examined a wild-type cag+ H. pylori strain (88-23) and isogenic cagA, picA1 or picB mutants. From previous studies, we know that the picA1 mutation has a polar effect on picB. As expected, stimulation with the wild-type strain 88-23 induced a predominant NF-{kappa}B binding complex in AGS cells that was not seen in unstimulated cells (Fig. 7Go, lanes 1 and2). The isogenic mutants that lacked expression of either picB or picA1 did not induce {kappa}B-DNA binding activity (lanes 4 and 5). The isogenic cagA- mutant induced {kappa}B-DNA binding activity (lane 3), and the dichotomy between the results for the cagA- mutant and the picA1- and picB- mutants, exactly parallel earlier results on induction of IL-8 mRNA and protein (16, 21). While the laboratory cagA- mutant still induces detectable {kappa}B binding activity in EMSA, the reproducible observation that H. pylori 88-23:cagA- induces significantly less transcriptional activity remains paradoxical. These data might suggest that the NF-{kappa}B complexes released by 88-23:cagA- are able to associate with DNA but are not in a properly modified, hyperphosphorylated form to activate transcription. Alternatively, given the diminished {kappa}B binding activities of wild-type cagA- H. pylori strains (Fig. 6Go, lanes 6–9), the laboratory 88-23:cagA- strain might use other gene products to facilitate the full transcriptional activation of {kappa}B-containing genes (e.g., picA1 or picB). As such, these results indicate that the increase in NF-{kappa}B binding activity may play an essential role in the observed activation of the IL-8 promoter induced by cag+ H. pylori strains, and this effect is dependent on the picA1 and/or picB gene products.



View larger version (101K):
[in this window]
[in a new window]
  		FIGURE 6. Wild-type cag+ H. pylori strains show enhanced stimulation of {kappa}B binding activity in AGS cells compared with wild-type cag- H. pylori strains. Equal protein concentrations of nuclear extracts from AGS cells that were unstimulated or cocultured with H. pylori were analyzed for {kappa}B binding by gel-shift assays. The {kappa}B probe was incubated with nuclear extracts from unstimulated AGS cells (lane 1) or cells cocultured with cag+ H. pylori strains N6 (lanes 2 and 3) or 88-23 (lanes 4 and 5) or cag- strains 88-22 (lanes 6 and 7) or 87-203 (lanes 8 and9). For lanes 3, 5, 7, and 9, the nuclear extracts were preincubated with RelA Ab for 30 min. The arrow indicates the location of the supershifted complex.

 


View larger version (68K):
[in this window]
[in a new window]
  		FIGURE 7. The pic gene products of H. pylori are required for induction of NF-{kappa}B binding activity in gastric epithelial cells. Equal protein concentrations of nuclear extracts from unstimulated AGS cells (lane 1) and cells cocultured with wt (lane 2), cagA- (lane 3), picA1- (lane 4), or picB- (lane 5) H. pylori strains were analyzed for {kappa}B.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
IL-8 is an important cytokine in the host inflammatory response to H. pylori (18, 41, 42), which correlates with its induction in gastric epithelial cells cocultured with H. pylori in vitro (20, 21, 40). Up-regulation of IL-8 by H. pylori may lead to free radical generation and the release of proteolytic enzymes from activated neutrophils, affecting mucosal integrity (43). That eradication of H. pylori in ulcer patients results in a reduction in antral IL-8 mRNA expression, in neutrophil infiltration, and in surface epithelial lesions (41), suggests that inflammatory cytokines may play an important role in the mucosal damage seen in H. pylori infection.

In this report we investigated the molecular mechanisms by which IL-8 gene expression is regulated upon exposure of gastric AGS cells to H. pylori variants. Our studies demonstrate that both NF-{kappa}B and NF-IL-6 elements are required for induction of IL-8 promoter activity in gastric AGS epithelial cells by both H. pylori and TNF-{alpha}, findings consistent with observations that intact binding sites of both {kappa}B and NF-IL-6 elements are required for maximal IL-8 expression in Jurkat T cells, by stimuli such as IL-1, TNF-{alpha}, and phorbol esters (30).

Our study further shows that a RelA-containing NF-{kappa}B binding complex is rapidly induced in response to H. pylori stimulation of AGS cells, whereas there is no increase in NF-IL-6 binding activity. Although, the NF-{kappa}B site is required for inducibility of the IL-8 enhancer in all cell types examined (29), the NF-IL-6 element also is necessary as a co-operator for IL-8 gene transcription (29, 30). In vitro DNA binding studies and transient transfection assays in Jurkat T cells and fibrosarcoma cells implicate RelA homodimer as the transcriptional activator binding to the {kappa}B-like site in the IL-8 enhancer (39), providing direct evidence for the role of RelA in the regulation of IL-8 gene expression. The classical NF-{kappa}B p50/RelA heterodimer does not appear to bind the IL-8 site in vitro and does not trans-activate transcription from the IL-8 promoter despite its ability to do so in cells transfected with Ig {kappa} or HIV {kappa}B site reporters (39).

Compared with cag- H. pylori strains, the more virulent cag+ strains showed an enhanced ability to induce RelA-NF-{kappa}B binding activity and IL-8 promoter activity, paralleling earlier observations that increased IL-8 induction in AGS cells was cag+ strain specific (20, 21). The current data indicate that increased IL-8 expression in epithelial cells in response to cag+ H. pylori strains may result from an increase in RelA binding to the cognate enhancer element in the IL-8 promoter. That the pic-encoded determinants expressed by cag+ strains required for IL-8 expression (10, 16) also are essential for inducing NF-{kappa}B binding and IL-8 promoter activity in AGS gastric cells confirms that the ability of wild-type and mutant H. pylori strains to activate NF-{kappa}B correlates with their ability to induce IL-8 expression.

Recent studies suggest that the cag pathogenicity island may encode a secretion system in H. pylori analogous to the hybrid-type secretion systems present in Yersinia, Bordetella, and Agrobacterium species that secrete factors involved in bacteria-host cell interactions (10). Whether inactivation of cag genes other than picA1 and picB affects NF-{kappa}B activation and IL-8 promoter activity in gastric epithelial cells, as they affect IL-8 secretion (10), remains to be determined.

The finding that H. pylori is a potent activator of NF-{kappa}B has important implications, since other NF-{kappa}B-responsive genes, including TNF-{alpha}, IL-1, and IL-6, which have been found to be elevated in the gastric mucosa of persons with H. pylori (44, 45), also may participate in the pathophysiology of H. pylori colonization. Co-operation between the NF-IL-6 and the NF-{kappa}B/Rel families of proteins in regulating immune, inflammatory response and acute phase response genes allows the perpetuation and amplification of inflammatory signals (24, 30, 31).

Colonization by H. pylori may lead to altered homeostasis in the gastric mucosa (3), causing an imbalance between proinflammatory and anti-inflammatory cytokines. Lack of type 2 cytokine responses in subjects colonized with H. pylori (46) helps explain the elevated levels of proinflammatory cytokines in the gastric mucosa (18, 41, 44, 45), since by inhibiting NF-{kappa}B activation, IL-10 suppresses the synthesis of proinflammatory cytokines, whereas IL-4 blocks cytokine mRNA accumulation (47).

In summary, the present studies demonstrate that IL-8 induction in AGS gastric cells by H. pylori is regulated via an NF-{kappa}B-dependent transcriptional process. The pic determinants expressed by cag+ strains play a critical role in NF-{kappa}B-mediated up-regulation of IL-8 expression, and the presence of these secretory pathway homologues may explain the heightened inflammatory response observed in subjects colonized with cag+ strains.


   Acknowledgments
 
We thank Charles Kunsch, Human Genomic Sciences, for providing the wild-type and mutant IL-8 CAT constructs. We gratefully acknowledge Roland Stein and members of his laboratory for useful discussions and sharing their expertise with gel shift and transfection assays.


   Footnotes
 
1 This work was supported by grants from the National Institutes of Health (to L.D.K. (R01GM51249), M.J.B. (RO1DK50838), and M.K.R.T (R29DK48451)), by the Medical Research Service of the Department of Veterans Affairs, and by a Young Investigatorship of the Cancer Research Institute and a Junior Faculty Research Award of the American Cancer Society (to L.D.K.). Back

2 Address correspondence and reprint requests to Dr. Lawrence D. Kerr, Departments of Microbiology and Immunology and Cell Biology, Vanderbilt University School of Medicine, Nashville, TN 37232–2363. E-mail address: Back

3 Abbreviations used in this paper: NF-{kappa}B, nuclear factor-{kappa}B; AP-1, activating protein-1; wt, wild type; CAT, chloramphenicol acetyltransferase; EMSA, electrophoretic mobility shift assay. Back

Received for publication July 17, 1997. Accepted for publication November 6, 1997.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Anonymous, . 1994. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease: NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. JAMA 272:65.[Medline]
  2. Blaser, M. J.. 1992. Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology. 102:720.[Medline]
  3. Blaser, M. J., J. Parsonnet. 1994. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J. Clin. Invest. 94:4.
  4. Dooley, C. P., P. L. Fitzgibbons, H. Cohen, M. D. Appleman, G. I. Pérez-Pérez, M. J. Blaser. 1989. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N. Engl. J. Med. 321:1562.[Abstract]
  5. Forman, D., D. G. Newell, F. Fullerton, J. W. Yarnell, A. R. Stacey, N. Wald, F. Sitas. 1991. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br. Med. J. 302:1302.
  6. Nomura, A., G. N. Stemmermann, P. Chyou, I. Kato, G. Perez-Perez, M. J. Blaser. 1991. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. N. Engl. J. Med. 325:1132.[Abstract]
  7. Blaser, M. J., G. I. Perez-Perez, H. Kleanthous, T. L. Cover, R. M. Peek, P. H. Chyou, G. N. Stemmermann, A. Nomura. 1995. Infection with Helicobacter pylori possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111.[Abstract/Free Full Text]
  8. Covacci, A., S. Censini, M. Bugnoli, R. Petracca, D. Burroni, G. Macchia, A. Massone, E. Papini, Z. Xiang, N. Figura, R. Rappvoli. 1993. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA 90:5791.[Abstract/Free Full Text]
  9. Crabtree, J. E., J. D. Taylor, J. I. Wyatt, R. V. Heatley, T. M. Shallcross, D. S. Tompkins, B. J. Rathbone. 1991. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338:332.[Medline]
  10. Censini, S., C. Lange, Z. Xiang, J. E. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli, A. Covacci. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648.[Abstract/Free Full Text]
  11. Leunk, R. D., P. T. Johnson, B. C. David, W. G. Kraft, D. R. Morgan. 1988. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol. 26:93.[Abstract]
  12. Figura, N., P. Gugliemetti, A. Rossolini, A. Barberi, G. Cusi, R. A. Musmanno, M. Russi, S. S. Quaranta. 1989. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J. Clin. Microbiol. 27:225.[Abstract/Free Full Text]
  13. Goosens, H., Y. Glupczynski, A. Burette, J.-P. Lambert, L. Vlaes, J.-P. Butzler. 1992. Role of the vacuolating toxin from Helicobacter pylori in the pathogenesis of duodenal and gastric ulcer. Med. Microbiol. Lett. 1:153.
  14. Schmitt, W., R. Haas. 1994. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported proteins. Mol. Microbiol. 12:307.[Medline]
  15. Telford, J. L., P. Ghiara, M. Dell’Orco, M. Comanducci, D. Burroni, M. Bugnoli, M. F. Tecce, S. Censini, A. Covacci, Z. Xiang, E. Papini, C. Montecucco, L. C., L. Parente, R. Rappuoli. 1994. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 179:1653.[Abstract/Free Full Text]
  16. Tummuru, M. K. R., S. A. Sharma, M. J. Blaser. 1995. Helicobacter pylori picB, a homolog of the Bordetella pertussis toxin secretory protein, is required for induction of Interleukin-8 in gastric epithelial cell lines. Mol. Microbiol. 18:867.[Medline]
  17. Cover, T. L., C. P. Dooley, M. J. Blaser. 1990. Characterization of and human serological responses to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect. Immun. 58:603.[Abstract/Free Full Text]
  18. Peek, R. M., G. G. Miller, K. T. Tham, G. I. Perez-Perez, X. Zhao, J. C. Atherton, M. J. Blaser. 1995. Heightened inflammatory response and cytokine response in vivo to cagA+ Helicobacter pylori strains. Lab. Invest. 73:760.[Medline]
  19. Oppenheim, J. J., C. O. C. Zachariae, N. Mukaida, K. Matsushima. 1991. Properties of the novel proinflammatory supergene intercrine cytokine family. Annu. Rev. Immunol. 9:617.[Medline]
  20. Crabtree, J. E., S. M. Farmery, I. J. D. Lindley, N. Figura, P. Peichl, D. S. Tompkins.. cagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cells. J. Clin. Pathol. 47:1994. b.945.[Abstract/Free Full Text]
  21. Sharma, S. A., M. K. R. Tummuru, G. G. Miller, M. J. Blaser. 1995. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect. Immun. 63:1681.[Abstract]
  22. Baeuerle, P. A., D. Baltimore. 1996. NF-{kappa}B: ten years after. Cell 87:13.[Medline]
  23. Barnes, P. J., M. Karin. 1997. Nuclear factor-{kappa}B: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066.[Free Full Text]
  24. Kopp, E. B., S. Ghosh. 1995. NF-{kappa}B and Rel proteins in innate immunity. Adv. Immunol. 58:1.[Medline]
  25. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, S. Miyamoto. 1995. Rel/NF-{kappa}B/I{kappa}B family: intimate tales of association and dissociation. Genes Dev. 9:2723.[Free Full Text]
  26. Dyer, R. B., C. R. Collaco, D. W. Niesel, N. K. Herzog. 1993. Shigella flexneri invasion of HeLa cells induces NF-{kappa}B DNA-binding activity. Infect. Immun. 61:4427.[Abstract/Free Full Text]
  27. Busam, K., C. Gieringer, M. Freudenberg, H.-P. Hohmann. 1992. Staphylococcus aureus and derived exotoxins induce nuclear factor {kappa}B-like activity in murine bone marrow macrophages. Infect. Immun. 60:2008.[Abstract/Free Full Text]
  28. Hauf, N., W. Goebel, E. Serfling, M. Kuhn. 1994. Listeria monocytogenes infection enhances transcription factor NF-{kappa}B in P388D1 macrophage-like cells. Infect. Immun. 62:2740.[Abstract/Free Full Text]
  29. Mukaida, N., S.-I. Okamoto, Y. Ishikawa, K. Matsushima. 1994. Molecular mechanisms of interleukin-8 gene expression. J. Leukocyte Biol. 56:554.[Abstract]
  30. Kunsch, C., R. K. Lang, C. A. Rosen, M. F. Shannon. 1994. Synergistic transcriptional activation of the IL-8 gene by NF-{kappa}B p65 (RelA) and NF-IL-6. J. Immunol. 153:153.[Abstract]
  31. Matsusaka, T., K. Funikawa, Y. Nishio, N. Mukaida, K. Matsushima, T. Kishimoto, S. Akira. 1993. Transcription factors NF-IL6 and NF-{kappa}B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. USA 90:10193.[Abstract/Free Full Text]
  32. Tummuru, M. K. R., T. L. Cover, M. J. Blaser. 1993. Cloning and expression of a high molecular weight major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun. 61:1799.[Abstract/Free Full Text]
  33. Graham, F. L., A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456.[Medline]
  34. Wigler, M., A. Pellicer, S. Silverstein, R. Axel. 1978. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 14:725.[Medline]
  35. Nordeen, S. K., III P. P. Green, D. M. Fowles. 1987. Laboratory methods: a rapid, sensitive, and inexpensive assay for chloramphenicol acetyl-transferase. DNA 6:173.[Medline]
  36. Schreiber, E., P. Matthias, M. M. Muller, W. Schaffner. 1989. Rapid detection of octamer binding proteins with ‘mini extracts,’ prepared from a small number of cells. Nucleic Acids Res. 17:6419.[Free Full Text]
  37. Bradford, M.. 1976. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.[Medline]
  38. Kerr, L. D.. 1995. Electrophoretic mobility shift assay. Methods Enzymol. 254:619.[Medline]
  39. Kunsch, C., C. A. Rosen. 1993. NF-{kappa}B subunit-specific regulation of the interleukin-8 promoter. Mol. Cell. Biol. 13:6137.[Abstract/Free Full Text]
  40. Crowe, S. E., L. Alvarez, M. Dytoc, R. H. Hunt, M. Muller, P. Sherman, J. Patel, Y. Jin, P. B. Ernst. 1995. Expression of interleukin-8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 108:65.[Medline]
  41. Moss, S. F., S. Legon, J. Davis, J. Calam. 1994. Cytokine gene expression in Helicobacter pylori-associated antral gastritis. Gut 35:1567.[Abstract/Free Full Text]
  42. Crabtree, J. E., J. I. Wyatt, L. K. Trejdosiewicz, P. Peichl, P. H. Nichols, N. Ramsay, J. N. Primrose, I. J. D. Lindley. 1994. a. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J. Clin. Pathol. 47:61.[Abstract/Free Full Text]
  43. Yoshida, N., D. N. Granger, D. J. Evans, D. G. Evans, D. Y. Graham, D. C. Anderson, R. E. Wolf, P. R. Kvietys. 1993. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 105:1431.[Medline]
  44. Crabtree, J. E., T. M. Shallcross, R. V. Heatley, J. I. Wyatt. 1991. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori-associated gastritis. Gut 32:1473.[Abstract/Free Full Text]
  45. Noach, L. A., N. B. Bosma, J. Jansen, F. J. J., S. J. H. Hoek, S. J. H. van Deventer, G. N. J. Tytgat. 1994. Mucosal tumor necrosis factor-{alpha}, interleukin-1ß, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol. 29:425.[Medline]
  46. Karttunen, R., T. Karttunen, H.-P. Ekre, T. T. MacDonald. 1995. Interferon {gamma} and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 36:341.[Abstract/Free Full Text]
  47. Wang, P., P. Wu, M. I. Siegel, R. E. Egan, M. M. Billah. 1995. IL-10 inhibits NF-{kappa}B activation in human monocytes (IL-10 and IL-4 suppress cytokine synthesis by different mechanisms). J. Biol. Chem. 270:9558.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
D. P. O'Brien, J. Romero-Gallo, B. G. Schneider, R. Chaturvedi, A. Delgado, E. J. Harris, U. Krishna, S. R. Ogden, D. A. Israel, K. T. Wilson, et al.
Regulation of the Helicobacter pylori Cellular Receptor Decay-accelerating Factor
J. Biol. Chem., August 29, 2008; 283(35): 23922 - 23930.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C.-H. Lai, Y.-C. Chang, S.-Y. Du, H.-J. Wang, C.-H. Kuo, S.-H. Fang, H.-W. Fu, H.-H. Lin, A.-S. Chiang, and W.-C. Wang
Cholesterol Depletion Reduces Helicobacter pylori CagA Translocation and CagA-Induced Responses in AGS Cells
Infect. Immun., July 1, 2008; 76(7): 3293 - 3303.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
M. Rizwan, A. Alvi, and N. Ahmed
Novel Protein Antigen (JHP940) from the Genomic Plasticity Region of Helicobacter pylori Induces Tumor Necrosis Factor Alpha and Interleukin-8 Secretion by Human Macrophages
J. Bacteriol., February 1, 2008; 190(3): 1146 - 1151.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. Tomimori, E. Uema, H. Teruya, C. Ishikawa, T. Okudaira, M. Senba, K. Yamamoto, T. Matsuyama, F. Kinjo, J. Fujita, et al.
Helicobacter pylori Induces CCL20 Expression
Infect. Immun., November 1, 2007; 75(11): 5223 - 5232.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. S. Gray and J. J. Pestka
Transcriptional Regulation of Deoxynivalenol-Induced IL-8 Expression in Human Monocytes
Toxicol. Sci., October 1, 2007; 99(2): 502 - 511.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S.-Z. Ding, Y. Minohara, X. J. Fan, J. Wang, V. E. Reyes, J. Patel, B. Dirden-Kramer, I. Boldogh, P. B. Ernst, and S. E. Crowe
Helicobacter pylori Infection Induces Oxidative Stress and Programmed Cell Death in Human Gastric Epithelial Cells
Infect. Immun., August 1, 2007; 75(8): 4030 - 4039.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Reyes-Leon, J. C. Atherton, R. H. Argent, J. L. Puente, and J. Torres
Heterogeneity in the Activity of Mexican Helicobacter pylori Strains in Gastric Epithelial Cells and Its Association with Diversity in the cagA Gene
Infect. Immun., July 1, 2007; 75(7): 3445 - 3454.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. H. Pillinger, N. Marjanovic, S.-Y. Kim, Y.-C. Lee, J. U. Scher, J. Roper, A. M. Abeles, P. I. Izmirly, M. Axelrod, M. Y. Pillinger, et al.
Helicobacter pylori Stimulates Gastric Epithelial Cell MMP-1 Secretion via CagA-dependent and -independent ERK Activation
J. Biol. Chem., June 29, 2007; 282(26): 18722 - 18731.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Saha, C. E. Hammond, M. Gooz, and A. J. Smolka
IL-1beta modulation of H,K-ATPase {alpha}-subunit gene transcription in Helicobacter pylori infection
Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1055 - G1061.
[Abstract] [Full Text] [PDF]

Home page
 J DAIRY SCIHome page
P. Boutet, J. Sulon, R. Closset, J. Detilleux, J.-F. Beckers, F. Bureau, and P. Lekeux
Prolactin-Induced Activation of Nuclear Factor {kappa}B in Bovine Mammary Epithelial Cells: Role in Chronic Mastitis
J Dairy Sci, January 1, 2007; 90(1): 155 - 164.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. M. O'Hara, A. Bhattacharyya, R. C. Mifflin, M. F. Smith, K. A. Ryan, K. G.-E. Scott, M. Naganuma, A. Casola, T. Izumi, S. Mitra, et al.
Interleukin-8 Induction by Helicobacter pylori in Gastric Epithelial Cells is Dependent on Apurinic/Apyrimidinic Endonuclease-1/Redox Factor-1
J. Immunol., December 1, 2006; 177(11): 7990 - 7999.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Hirata, T. Ohmae, W. Shibata, S. Maeda, K. Ogura, H. Yoshida, T. Kawabe, and M. Omata
MyD88 and TNF Receptor-Associated Factor 6 Are Critical Signal Transducers in Helicobacter pylori-Infected Human Epithelial Cells
J. Immunol., March 15, 2006; 176(6): 3796 - 3803.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Krueger, T. Hundertmark, T. Kalinski, U. Peitz, T. Wex, P. Malfertheiner, M. Naumann, and A. Roessner
Helicobacter pylori Encoding the Pathogenicity Island Activates Matrix Metalloproteinase 1 in Gastric Epithelial Cells via JNK and ERK
J. Biol. Chem., February 3, 2006; 281(5): 2868 - 2875.
[Abstract] [Full Text] [PDF]